Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
The Lancet. Oncology|April 20, 2012
Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trialLi Zhang, Shenglin Ma, Xiangqun Song, et al.
Scientific Reports|August 18, 2017
Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR statusHong Jian, Wei Li, Zhiyong Ma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 30, 2014
Final overall survival results from a phase III, randomized, placebo-controlled, parallel-group study of gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804)Hongyun Zhao, Yun Fan, Shenglin Ma, et al.
Life (Basel, Switzerland)|November 11, 2022
Genome-Wide Identification of LeBAHDs in Lithospermum erythrorhizon and In Vivo Transgenic Studies Confirm the Critical Roles of LeBAHD1/LeSAT1 in the Conversion of Shikonin to AcetylshikoninXuan Wang, Zhuoyu He, Huan Yang, et al.
Cancer Letters|February 25, 2026
Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancerYidan Chen, Huayang Xing, Xinyu Yang, et al.
Frontiers in Oncology|July 5, 2021
Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary ComponentShirong Zhang, Yang Xu, Pan Zhao, et al.
Nature Communications|September 14, 2023
DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissuesShirong Zhang, Shutao He, Xin Zhu, et al.
Radiation Oncology (London, England)|January 15, 2021
Deep learning-based automatic delineation of the hippocampus by MRI: geometric and dosimetric evaluationKaicheng Pan, Lei Zhao, Song Gu, et al.
Signal Transduction and Targeted Therapy|January 4, 2024
Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activityTao Yuan, Chenming Zeng, Jiawei Liu, et al.
Annals of the Rheumatic Diseases|January 31, 2013
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trialIain B McInnes, Joachim Sieper, Jürgen Braun, et al.
Pageof 22